Development of dual SST 2 /SST 5 targeting radioligands through rational structural design
Year: 2026
Type: article
Abstract: Development of a high affinity dual SST 2 agonist/SST 5 antagonist radioligand for improved targeting and imaging of somatostatin receptor-expressing tumors.
Source: RSC Medicinal Chemistry
DOI: 10.1039/d6md00646a
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W7220455835
